Innovations in the surgical and therapeutic management of extensive infantile hemangiomas: a systematic analysis of functional and aesthetic outcomes
DOI:
https://doi.org/10.56183/iberojhr.v4i2.697Palavras-chave:
Hemangioma, Therapeutic Use, Laser Therapy, Reconstructive Surgical Procedures, Treatment Outcome.Resumo
This systematic analysis is conducted to evaluate advancements in managing extensive infantile hemangiomas (IH). The focus is on functional and aesthetic outcomes for infantile hemangiomas (IH) infants who undergo most recent treatments. IH benign vascular tumors affecting 4-10% of infants that can disrupt vital functions and present aesthetic concerns. Treatments like propranolol which is a beta-blocker have revolutionized care with 90% effectiveness but limitations persist, particularly in addressing residual scarring and tissue remodeling. Study employs a systematic review methodology under PRISMA guidelines while analyzing global IH data and therapeutic advancements and including beta-blockers, laser therapy and combination treatments. We suggest propranolol is a good option for its role in reducing IH size and severity and laser therapy enhancing results for complex cases. Combination therapies like propranolol with laser or topical agents improve efficacy while minimizing side effects and advanced techniques such as pulsed dye laser and Nd: YAG have been effective but are mostly used for residual scars. Despite improvements there are gaps remain in understanding long-term outcomes or recurrence rates and other gaps are concerning to patient satisfaction. We warrant integrated multidisciplinary approaches to improve care. Regional disparities in IH management are noted with limited access to timely diagnosis in low-income regions while future research should focus on personalized treatment strategies and safety and optimizing therapeutic combinations to enhance both functional and aesthetic outcomes. Regional disparities in IH management are noted, with limited access to timely diagnosis in low-income regions. Future research should focus on personalized treatment strategies, safety, and optimizing therapeutic combinations to enhance both functional and aesthetic outcomes.
Referências
Smith, C. J. F., Friedlander, S. F., Guma, M., Kavanaugh, A., & Chambers, C. D. (2017). Infantile Hemangiomas: An Updated Review on Risk Factors, Pathogenesis, and Treatment. Birth defects research, 109(11), 809–815. https://doi.org/10.1002/bdr2.1023
Yuzuriha, S., Nagai, F., & Noguchi, M. (2019). How to Manage Disfiguring Scars in Involuted Infantile Hemangioma. Advances in wound care, 8(6), 221–229. https://doi.org/10.1089/wound.2018.0847
Jung HL. Update on infantile hemangioma. Clinical and experimental pediatrics. 2021 Nov;64(11):559.
Bandera AI, Sebaratnam DF, Wargon O, Wong LC. Infantile hemangioma. Part 1: Epidemiology, pathogenesis, clinical presentation and assessment. Journal of the American Academy of Dermatology. 2021 Dec 1;85(6):1379-92.
Itinteang T, Withers AH, Davis PF, Tan ST. Biology of infantile hemangioma. Frontiers in surgery. 2014 Sep 25;1:38.
Mulliken JB. Diagnosis and natural history of hemangiomas. Mulliken and Young’s Vascular Anomalies: Hemangiomas and Malformations. 1988;4:68-110.
Ng MS, Tay YK. Laser treatment of infantile hemangiomas. Indian Journal of Paediatric Dermatology. 2017 Jul 1;18(3):160-5.
Zimmermann AP, Wiegand S, Werner JA, Eivazi B. Propranolol therapy for infantile haemangiomas: review of the literature. International journal of pediatric otorhinolaryngology. 2010 Apr 1;74(4):338-42.
Starkey E, Shahidullah H. Propranolol for infantile haemangiomas: a review. Archives of disease in childhood. 2011 Sep 1;96(9):890-3.
Colmant C, Powell J. Medical management of infantile hemangiomas: An update. Pediatric Drugs. 2022 Jan;24(1):29-43.
Chen ZY, Wang QN, Zhu YH, Zhou LY, Xu T, He ZY, Yang Y. Progress in the treatment of infantile hemangioma. Annals of translational medicine. 2019 Nov;7(22).
Khan M, Boyce A, Prieto-Merino D, Svensson Å, Wedgeworth E, Flohr C. The role of topical timolol in the treatment of infantile hemangiomas: a systematic review and meta-analysis. Acta dermato-venereologica. 2017;97(10):1167-71.
Izadpanah A, Izadpanah A, Kanevsky J, Belzile E, Schwarz K. Propranolol versus corticosteroids in the treatment of infantile hemangioma: a systematic review and meta-analysis. Plastic and reconstructive surgery. 2013 Mar 1;131(3):601-13.
Wang C, Sun J, Guo L, Song D, Zhang X, Liu Z, Wang L. Low-dose sclerotherapy with lauromacrogol in the treatment of infantile hemangiomas: A retrospective analysis of 368 cases. Frontiers in Oncology. 2022 Nov 8;12:1014465.
Chandra, S.R. ed., 2023. Molecular, Therapeutic, and Surgical Updates on Head and Neck Vascular Anomalies, An Issue of Oral and Maxillofacial Surgery Clinics of North America: Molecular, Therapeutic, and Surgical Updates on Head and Neck Vascular Anomalies, An Issue of Oral and Maxillofacial Surgery Clinics of North America, E-Book (Vol. 36, No. 1). Elsevier Health Sciences.
Khamaysi Z, Jiryis B, Zoabi R, Avitan‐Hersh E. Laser treatment of infantile hemangioma. Journal of Cosmetic Dermatology. 2023 Jun;22:1-7.
Roca IC, Cojocaru E, Rusu CD, Trandafir LM, Săveanu CI, Lupu VV, Butnariu LI, Ţarcă V, Moscalu M, Bernic J, Lupu A. The Role of Natural Extracts in the Management of Infantile Hemangiomas and Vascular Tumors. Pediatric Health, Medicine and Therapeutics. 2024 Dec 31:1-6.
Raphael MF, Breur JM, Vlasveld FA, Elbert NJ, Liem YT, Kon M, Breugem CC, Pasmans SG. Treatment of infantile hemangiomas: therapeutic options in regard to side effects and adverse events–a review of the literature. Expert opinion on drug safety. 2016 Feb 1;15(2):199-214.
Kim JH, Lam JM. Paediatrics: how to manage infantile haemangioma. Drugs in Context. 2021;10.
Blatt J, McLean TW, Castellino SM, Burkhart CN. A review of contemporary options for medical management of hemangiomas, other vascular tumors, and vascular malformations. Pharmacology & therapeutics. 2013 Sep 1;139(3):327-33.
Hou, J., Wang, M., Tang, H., Wang, Y., & Huang, H. (2011). Pingyangmycin sclerotherapy for infantile hemangiomas in oral and maxillofacial regions: an evaluation of 66 consecutive patients. International journal of oral and maxillofacial surgery, 40(11), 1246–1251. https://doi.org/10.1016/j.ijom.2011.07.906
Sugimoto, A., Aoki, R., Toyohara, E., & Ogawa, R. (2021). Infantile Hemangiomas Cleared by Combined Therapy With Pulsed Dye Laser and Propranolol. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 47(8), 1052–1057. https://doi.org/10.1097/DSS.0000000000003018
Zou, Y., Wu, Z., Jin, P., Fu, R., Cheng, J., Bai, H., Huang, M., Huang, X., & Yuan, H. (2024). Historical and contemporary management of infantile hemangiomas: a single-center experience. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1280948
Fei Q, Lin Y, Chen X. Treatments for infantile Hemangioma: A systematic review and network meta-analysis. EClinicalMedicine. 2020 Sep 1;26.
Khamaysi Z, Jiryis B, Zoabi R, Avitan‐Hersh E. Laser treatment of infantile hemangioma. Journal of Cosmetic Dermatology. 2023 Jun;22:1-7.
Sun X, Liu X, Lu N, Yao S, Xu X, Niu L. Short term curative effect and safety of propranolol combined with laser in the treatment of infantile hemangiomas. Oncology letters. 2018 Nov 1;16(5):6561-5.
Satterfield KR, Chambers CB. Current treatment and management of infantile hemangiomas. Survey of ophthalmology. 2019 Sep 1;64(5):608-18.
Léauté-Labrèze C, Harper JI, Hoeger PH. Infantile haemangioma. The Lancet. 2017 Jul 1;390(10089):85-94.
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2024 Karla Enith Guamán Cevallos , Elizabeth Arellano Pacheco, Amairani Tovar García, Leonela Valdes Cabello, Pedro Miguel Hernández Valdelamar
Este trabalho está licenciado sob uma licença Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
